Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Follow up Efficacy and Safety Study of BAL4979 in the Treatment of Chronic Hand Dermatitis Refractory to Topical Treatment

NCT00124436 is registered in ClinicalTrials.gov with Basilea Pharmaceutica as lead sponsor.

NCT NCT00124436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00124436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Follow up Efficacy and Safety Study of BAL4979 in the Treatment of Chronic Hand Dermatitis Refractory to Topical Treatment
Lead sponsor
Basilea Pharmaceutica
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2005
Completion date
February 28, 2007
Enrollment
300
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hand dermatoses